https://www.labpulse.com/diseases/cancer/non-small-cell-lung-cancer/article/15306749/cart-cell-therapies-eliminate-residual-drugresistant-lung-cancer-cells-in-preclinical-tests
0
0
2/13/23 at 5:12pm
Organization
Labpulse.com
Author
Nick Paul Taylor
49 words
0
Comments
The analysis showed that CD70, a cell surface protein normally found on immune cells, is highly overexpressed by drug-resistant cells and the residual cells that remain immediately after treatment with an EGFR TKI.
You are the first to view
Create an account
or login to join the discussion